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Summary
Leptin is required for normal energy and glucose homeostasis. The hypothalamic arcuate nucleus (ARH) has been pro-
posed as an important site of leptin action. To assess the physiological significance of leptin signaling in the ARH, we
used mice homozygous for a FLPe-reactivatable, leptin receptor null allele (Leprneo/neo mice). Similar to Leprdb/db mice,
these mice are obese, hyperglycemic, hyperinsulinemic, infertile, and hypoactive. To selectively restore leptin signaling in
the ARH, we generated an adeno-associated virus expressing FLPe-recombinase, which was delivered unilaterally into the
hypothalamus using stereotaxic injections. We found that unilateral restoration of leptin signaling in the ARH of Leprneo/neo
mice leads to a modest decrease in body weight and food intake. In contrast, unilateral reactivation markedly improved
hyperinsulinemia and normalized blood glucose levels and locomotor activity. These data demonstrate that leptin signaling
in the ARH is sufficient for mediating leptin’s effects on glucose homeostasis and locomotor activity.Introduction
Leptin is secreted by adipocytes and signals to the brain the
status of the body’s energy content (Spiegelman and Flier,
2001; Friedman, 2004). Mice lacking leptin (Lepob/ob mice) or
leptin receptor signaling (Leprdb/db mice) are obese, diabetic,
infertile, and hypoactive (Chen et al., 1996; Chua et al., 1996;
Lee et al., 1996; Tartaglia et al., 1995; Zhang et al., 1994; Cole-
man, 1978). Recently, it has also been shown that leptin plays
a critical role in neuronal plasticity (Pinto et al., 2004; Bouret et
al., 2004). Substantial evidence suggests that the brain medi-
ates the majority of leptin’s action on energy homeostasis. For
example, deletion of leptin receptors (LEPRs) in neurons in-
duces obesity (Cohen et al., 2001), whereas expression of
LEPRs in neurons of Leprdb/db mice leads to an amelioration
of their obesity (Kowalski et al., 2001). Moreover, intracerebro-
ventricular (icv) administration of leptin in Lepob/ob mice causes
reduction of body weight and food intake (Campfield et al.,
1995).
Among the five splice variants described in mice (Lee et al.,
1996), the long form of the leptin receptor (LEPR-B) is required
for normal body weight homeostasis (Chen et al., 1996; Lee et
al., 1996). Within the brain, abundant expression of LEPR-B
has been found in several sites including hypothalamic groups
such as the arcuate (ARH), the ventromedial (VMH), the dor-
somedial (DMH), and the ventral premammillary (PMV) nuclei
(Mercer et al., 1996; Elmquist et al., 1998; Fei et al., 1997;
Schwartz et al., 1996; Thornton et al., 1997). Prominent amongCELL METABOLISM : JANUARY 2005 · VOL. 1 · COPYRIGHT © 2005 ELthese, the ARH has been proposed as an important site for
mediating leptin’s effect on energy homeostasis (Cowley et al.,
2003; Schwartz et al., 2003; Zigman and Elmquist, 2003). In-
deed, several reports support this view: Takeda et al. (2002)
demonstrated that icv leptin infusion failed to reduce body
weight in ARH-lesioned Lepob/ob mice. Moreover, ARH-specific
LEPR-B gene therapy in rats lacking functional leptin receptor
results in an amelioration of the obese phenotype (Morton et
al., 2003). The ARH contains two populations of first-order, lep-
tin-responsive neurons: The orexigenic NPY/AGRP and the
anorexigenic CART/POMC neurons (Spiegelman and Flier,
2001; Saper et al., 2002). NPY/AGRP neurons are directly in-
hibited by leptin (van den Top et al., 2004), whereas CART/
POMC neurons are directly activated by leptin (Cowley et al.,
2001; Elias et al., 1999). Consistent with this, Lepob/ob mice
have increased hypothalamic Agrp and Npy mRNA levels (Mi-
zuno and Mobbs, 1999; Schwartz et al., 1996; Ahima et al.,
1996; Stephens et al., 1995) and reduced Pomc mRNA levels
(Schwartz et al., 1997; Thornton et al., 1997). Further support-
ing the importance of the ARH in controlling leptin actions on
energy homeostasis, we have recently shown that mice lacking
LEPRs only in POMC neurons are mildly obese (Balthasar et
al., 2004).
In addition to the well-documented effects on body weight,
leptin signaling is required for normal glucose homeostasis as
demonstrated by the fact that both Lepob/ob and Leprdb/dbSEVIER INC. DOI:10.1016/j.cmet.2004.12.004 63
A R T I C L Emice have impaired insulin/glucose homeostasis (Spiegelman
and Flier, 2001; Pelleymounter et al., 1995; Coleman, 1978).
However, it is still unclear whether leptin regulates glucose ho-
meostasis directly or indirectly through its action on body
weight. Several studies support the view that leptin does have
an effect on glucose homeostasis independent of its effect on
body weight regulation. For example, Pelleymounter et al.
(1995) reported that daily leptin administration in Lepob/ob
mice, at doses that did not have an effect on body weight,
normalized serum glucose level. Moreover, Schwartz et al.
(1996) showed that leptin-treated Lepob/ob mice had 40%
greater reduction in glucose level compared with pair-fed
Lepob/ob control mice. Furthermore, Shimomura et al. (1999)
described that adipose-deficient, leptin-deficient, lipodystro-
phic mice are insulin resistant and that insulin sensitivity can
be restored in these mice by leptin infusion. This effect was
also independent of leptin’s action on body weight. To date, it
is unclear whether leptin’s effects on insulin-target tissues are
mediated indirectly by the brain or directly by LEPRs in these
tissues (Kamohara et al., 1997; Minokoshi et al., 2002).
As previously stated, leptin directly acts on NPY/AGRP and
CART/POMC neurons. Thus, the NPY pathway and the mela-
nocortin pathway might be involved in leptin-mediated control
of glucose homeostasis. Indeed, Lepob/ob mice lacking the Npy
gene (Lepob/ob; Npy−/− mice) have almost normal serum glu-
cose levels and 50% reduced insulinemia compared to
Lepob/ob mice (Erickson et al., 1996). Leptin activates the mela-
nocortin pathway by stimulating melanocortinergic POMC neu-
rons and by inhibiting AGRP neurons (AGRP is the natural an-
tagonist at the melanocortin receptors) (Cowley et al., 2001;
Elias et al., 1999; Elmquist et al., 1999; Schwartz et al., 1996;
Roseberry et al., 2004). Recently, it has also been shown that
central melanocortin signaling regulates insulin action. For ex-
ample, icv infusion of either the natural agonist (α-melanocyte
stimulating hormone [α-MSH]) or the synthetic antagonist
(SHU9119) of the melanocortin receptors 3 and 4 (MC3R and
MC4R) in rats has opposite effects. α-MSH-treated rats have
enhanced insulin action, whereas SHU9119-treated rats have
diminished insulin action (Obici et al., 2001).
Leptin signaling has also been shown to be a critical regula-
tor of reproductive function. Indeed both Lepob/ob and Leprdb/db
mice are infertile (Spiegelman and Flier, 2001; Bates et al.,
2003; Coleman, 1978). The NPY pathway has been proposed
to mediate leptin’s effect on reproductive function. Consistent
with this hypothesis, Lepob/ob; Npy−/− mice have improved fer-
tility (Erickson et al., 1996). Also, in agreement with this, mice
lacking leptin-mediated STAT3 activation, which are obese but
have normal hypothalamic Npy gene expression, are fertile
(Bates et al., 2003).
Finally, leptin exerts also a positive action on locomotor ac-
tivity as suggested by the fact that Lepob/ob mice are hypo-
active and that their locomotor activity can be normalized by
leptin treatment (Pelleymounter et al., 1995). To examine whether
leptin signaling only in ARH neurons is sufficient to prevent obe-
sity, diabetes, infertility, and hypoactivity, we re-expressed LEPRs
under the control of the endogenous leptin receptor promoter in
neurons in the ARH of mice otherwise deficient in leptin recep-
tor expression.64Results
Restoring leptin receptor expression
in the arcuate nucleus
In order to selectively express LEPRs in ARH neurons, we em-
ployed Leprneo/neo mice (McMinn et al., 2004). These mice are
homozygous for a FLPe-reactivatable, Lepr-null allele (Figure
1B) and, as a result, are similar to Leprdb/db mice (McMinn et
al., 2004). FLPe-mediated deletion of the FRT-flanked Neo cas-
sette creates a normally functioning Lepr allele. Indeed, mice
homozygous for the FLPe-reactivated, Lepr allele (Leprflox/flox
mice, Figure 1C) had body weights indistinguishable from wild-
type littermates (McMinn et al., 2004; Balthasar et al., 2004).
Site-specific reactivation of the Lepr allele was achieved by
stereotaxic delivery of FLPe-recombinase in Leprneo/neo male
mice. Due to the unavailability of antibodies for FLPe-recombi-
nase and in order to visualize FLPe-expressing cells in stereo-
taxically injected Leprneo/neo mice, we engineered an adeno-
associated viral vector that would also express enhanced
green fluorescent protein (eGFP) (Figure 1A). Therefore, we
were able to visualize FLPe-expressing cells by performing
immunohistochemistry for eGFP.
The AAV-FLPe-IRES-eGFP vector was stereotaxically in-
jected into the hypothalamus with coordinates focused on the
ARH of Leprneo/neo mice. This procedure inherently resulted in
a high percentage of injection sites that were centered outside
of the ARH as well as several injections that were centered in
the ARH. However, these missed injections served as impor-
tant anatomic controls. Thus, we categorized the injections as
either ARH-misses (control group) or ARH-hits first by neuro-
anatomic inspection. In addition, as described in Experimental
procedures, we also categorized the injections by counting
eGFP-positive cells within the hypothalamus. Briefly, brains
that had >100 eGFP-positive cells in the ARH (25 m sections
containing the ARH in a 1:5 series) were scored as ARH-hit.
Those cases with <100 eGFP-positive cells in the ARH were
grouped as ARH-missed. Importantly, we also obtained cases
that had >100 eGFP-positive cells in the ARH plus in other
nuclei which are known to contain Lepr-bmRNA (e.g., the DMH
and the VMH). These cases with ARH rescue plus the addi-
tional sites were not categorized in the ARH-hit group. Figures
2A and 2B show representative photomicrographs of im-
munohistochemistry for eGFP in ARH-missed and ARH-hit
Leprneo/neo mice, respectively. The eGFP immunohistochem-
istry was used as an index to categorize the center of the injec-
tion sites and, thus, the site containing the majority of FLPe-
expressing cells. We also determined whether the delivery of
FLPe successfully restored leptin signaling in transduced neu-
rons. To accomplish this, we assessed the rapid phosphoryla-
tion and nuclear translocation of signal transducer and activa-
tor of transcription 3 (STAT3) in response to leptin (Munzberg
et al., 2003; Li and Friedman, 1999; Baumann et al., 1996;
Hosoi et al., 2002). Therefore, 45 min before perfusion, mice
were injected intraperitoneally with leptin, and phospho-STAT3
(P-STAT3) immunohistochemistry was performed. As can be
seen in Figure 2C, ARH-missed cases displayed very modest
leptin-induced P-STAT3 immunoreactivity in the ARH. In con-
trast, prominent P-STAT3 immunoreactivity was characteristi-
cally observed in mice with ARH-specific restoration of leptin
receptor signaling (Figure 2D). The hypothalamic distribution
of leptin-induced P-STAT3-positive neurons in these mice isCELL METABOLISM : JANUARY 2005
Leptin action in the hypothalamic arcuate nucleusFigure 1. Schematic representation of adeno-asso-
ciated viral (AAV) vector and modified Lepr alleles
A) AAV-FLPe-IRES-eGFP was obtained by cloning
the FLPe gene into a transfer vector (pAAV-M2-
IGFP) such that FLPe and eGFP are driven by CMV
regulatory elements.
B) The FRT-Neo-FRT cassette is located upstream
of exon 17 of the Lepr allele. This allele was bred to
homozygosity to generate Leprneo/neo mice.
C) The FLPe-mediated removal of the FRT-Neo-FRT
cassette produces the FRT-modified and loxP-
flanked Lepr allele which functions as a wild-type
allele. Leprflox/flox mice are homozygous for this
allele.
D) The CRE-deleted Lepr allele lacks exon 17 and
is a null allele. Lepr/ mice are homozygous for
this allele.outlined in Table 1. These data demonstrate that leptin signal-
ing was established in ARH-neurons of Leprneo/neo mice.
We also attempted to rule out the possibility that the viral
injections and/or the expression of FLPe and eGFP by neurons
in the ARH per se had effects on body weight and glucose
homeostasis in obese and diabetic mice. We performed the
following experiment. The AAV-FLPe-IRES-eGFP vector was
stereotaxically injected into the hypothalamus with coordinates
focused on the ARH of mice homozygous for a Lepr-null allele
that cannot be reactivated by FLPe (LeprD/D mice, Figure 2D).
LeprD/D mice were categorized as ARH-hit and ARH-missed as
described above and in Experimental procedures. Figures 3A
and 3B show representative photomicrographs of immuno-
histochemistry for eGFP in ARH-missed and ARH-hit LeprD/D
mice, respectively. Both, ARH-missed and ARH-hit LeprD/D
mice displayed no leptin-induced P-STAT3 immunoreactivity
(Figures 3C and 3D, respectively). Importantly, ARH-missed
and ARH-hit LeprD/D mice had indistinguishable body weight
(12-week-old LeprD/Dmice: ARH-missed = 50.02 [g] ± 1.85 [n =
6]; ARH-hit = 51.12 [g] ± 1.6 [n = 3], Figure 4C). These mice
also had indistinguishable serum insulin (12-week-old LeprD/D
mice: ARH-missed = 89.22 ng/ml ± 18.21 [n = 4]; ARH-hit = 80.88
ng/ml ± 27.58 [n = 3], Figure 5B) and glucose levels (12-week-
old LeprD/D mice: ARH-missed = 492.5 mg/dl ± 34.17 [n = 4];
ARH-hit = 562 mg/dl ± 81.6 [n = 3], Figure 5D). These data
demonstrate that the viral injections and/or the expression of
FLPe and eGFP in neurons in the ARH had no effects on body
weight and glucose homeostasis in obese and diabetic mice.
Leptin action in the arcuate nucleus reduces body weight
Mice lacking leptin signaling have excessive body and fat
mass, increased food intake, and reduced energy expenditure
(Spiegelman and Flier, 2001; Friedman, 2004). Thus, we investi-CELL METABOLISM : JANUARY 2005gated the possibility that re-establishment, unilaterally, of leptin
signaling in ARH neurons would be sufficient to restore normal
energy homeostasis in Leprneo/neo mice. As shown in Figure
4A, ARH-hit Leprneo/neo mice had significantly reduced body
weight (starting at 7 weeks of age) when compared to ARH-
missed Leprneo/neo mice. We found that the difference in body
weight between 12-week-old ARH-hit Leprneo/neo mice and
ARH-missed Leprneo/neo mice was 5.2 g. This represented ap-
proximately 22% of the total body weight difference between
mice with normal leptin signaling (not surgically treated Lepr+/+
mice) and ARH-missed Leprneo/neo mice (Figure 4B). Body
composition analysis revealed that the reduction in body
weight observed in ARH-hit Leprneo/neo mice was due to a re-
duction in fat mass (Figure 4D). Since ARH-hit Leprneo/neo mice
had improved energy homeostasis, they must have either re-
duced food intake or increased energy expenditure or both.
ARH-hit Leprneo/neo mice had reduced cumulative food intake
(Figure 4E). However, energy expenditure was not elevated in
these mice (Figure 4F). These data suggest that leptin signaling
in one side of the ARH is sufficient to mediatew20% of leptin’s
action on body weight homeostasis.
Restoration of leptin receptors in the arcuate nucleus
dramatically improves glucose homeostasis
As noted, leptin signaling is required for normal blood glucose
and insulin levels. In fact, Lepob/ob mice and Leprdb/db mice
develop overt diabetes (Spiegelman and Flier, 2001; Coleman,
1978). We found that unilateral restoration of leptin signaling in
the ARH was sufficient to remarkably improve glucose homeo-
stasis in Leprneo/neo mice. Indeed, insulinemia was greatly re-
duced at both 4 and 8 weeks after FLPe-recombinase was de-
livered into the ARH of Leprneo/neo mice (Figure 5A). Notably, 4
weeks after surgery, the blood glucose levels in ARH-hit65
A R T I C L EFigure 2. Unilateral Lepr gene reactivation in the
ARH of Leprneo/neo mice
Photomicrograph of immunohistochemistry for eGFP
in ARH-missed (A; Case 17 in Table 1) and ARH-hit
(B; Case 9 in Table 1) Leprneo/neo mice. Photomicro-
graph of immunohistochemistry for leptin-induced
phospho-STAT3 in ARH-missed (C; Case 17) and
ARH-hit (D; Case 9) Leprneo/neo mice. Median emi-
nence (ME), third ventricle (3V), hypothalamic arcu-
ate nucleus (ARH). Scale bar = 100 m.Leprneo/neo mice were not statistically reduced compared to
that of ARH-missed Leprneo/neo mice (although a trend toward
lower glycemia was seen). However, at 8 weeks after surgery,
blood glucose levels were normalized. Indeed, we found that
12-week-old ARH-hit Leprneo/neo mice had blood glucose
levels indistinguishable to age-matched Lepr+/+ mice (Figure
5C). These data strongly suggest that insulin action was greatly
improved in ARH-hit Leprneo/neo mice.
Arcuate nucleus leptin receptors and reproduction
Leptin is also known to affect fertility. In fact, mice lacking lep-
tin signaling are infertile (Spiegelman and Flier, 2001; Coleman,
1978; Bates et al., 2003). Therefore, we tested whether ARH-hit
Leprneo/neo male mice were able to produce offspring by breed-
ing these male mice for one week with adult females. The
one-week breeding period was chosen because in similar
housing conditions, adult wild-type male mice were able to im-
pregnate adult wild-type female mice in this window of time.
All male mice (n = 4) that were bred with female mice for 6–7
days generated offspring. In contrast, both ARH-hit and
ARH-missed Leprneo/neo mice were unable to produce off-
spring. Indeed, none of the females were found to be pregnant
after the one-week breeding period. These data indicate that
unilateral leptin signaling in the ARH is insufficient to restore
the capacity of Leprneo/neo male mice to generate offspring.
Leptin action in the arcuate nucleus
and locomotor activity
Leptin positively regulates locomotor activity as supported by
the fact that Lepob/ob mice are hypoactive and their total activ-
ity can be normalized by leptin administration (Pelleymounter
et al., 1995). To date, it is unknown which sites in the brain
mediate this effect of leptin. In order to assess if ARH neurons66are able to mediate leptin’s effect on locomotor activity, we
recorded ambulatory movements of ARH-hit Leprneo/neo and
ARH-missed Leprneo/neo mice. As shown in Figure 6A, ARH-hit
Leprneo/neo mice had significantly increased 24 hr locomotor
activity when compared to ARH-missed Leprneo/neo mice. No-
tably, the majority of the increase in activity occurred during the
dark cycle (Figures 6B and 6C). Since the ambulatory activity of
ARH-hit Leprneo/neo mice was not statistically different to that
of wild-type control mice (Figure 6A), we conclude that
leptin-sensitive, ARH neurons are sufficient for mediating the
majority, if not all of leptin’s action on locomotor activity.
Discussion
The incidence of obesity and diabetes continues to rise in in-
dustrialized countries (Flier, 2004; Friedman, 2004; Barsh et al.,
2000). In order to prevent and/or treat these conditions it is
critical to understand the cellular and neuroanatomic pathways
that control energy and glucose homeostasis. The hormone
leptin is required for normal body weight and glucose homeo-
stasis and is key in governing these biological programs (Flier,
2004; Friedman, 2004; Barsh et al., 2000). During the last de-
cade it has become evident that leptin’s primary site of action
is the central nervous system (CNS). However, leptin receptors
are expressed in several CNS sites and relatively little is known
about which neuronal groups mediate each of the specific ac-
tions of leptin. The arcuate nucleus in the hypothalamus has
been proposed as one important site for mediating leptin’s ef-
fect on energy homeostasis (Cowley et al., 2003; Schwartz et
al., 2003; Zigman and Elmquist, 2003). Supporting this view,
we have shown that deletion of LEPRs only in POMC cells
leads to mild obesity (Balthasar et al., 2004). In addition,
Morton et al. (2003) performed ARH-specific Lepr-b gene ther-CELL METABOLISM : JANUARY 2005
Leptin action in the hypothalamic arcuate nucleusTable 1. Hypothalamic distribution of leptin-induced P-STAT3 positive neurons in ARH-missed and ARH-hit Leprneo/neo mice
ARH RCA VMH DMH LH Sch
Lt Rt Lt Rt Lt Rt Lt Rt Lt Rt Lt Rt
ARH-hit Leprneo/neo mice
1 531 44 16 9 14 0 1 0 0 0 0 0
2 525 96 20 9 8 0 152 0 25 0 0 0
3 213 25 4 2 0 0 0 0 0 0 0 0
4 364 43 0 0 0 0 0 2 0 0 0 0
5 606 7 23 0 41 0 75 0 0 0 0 0
6 411 77 15 16 7 2 0 0 0 0 4 0
7 432 136 26 11 3 0 0 0 0 0 0 0
8 325 31 7 3 2 0 0 0 0 0 0 0
9 360 63 10 0 23 0 11 0 1 0 0 0
ARH-missed Leprneo/neo mice
10 25 18 22 23 1 1 0 0 0 0 0 3
11 16 4 0 0 0 0 0 0 0 0 0 0
12 6 2 1 0 0 0 0 0 0 0 0 0
13 62 32 17 14 0 0 0 0 0 0 3 12
14 74 7 19 2 12 0 17 0 0 0 0 0
15 7 4 0 0 0 0 0 0 0 0 0 0
16 1 6 0 0 0 0 0 0 0 0 0 0
17 81 51 17 11 7 0 2 0 0 0 0 0
18 2 5 11 12 0 0 0 0 0 0 0 4
P-STAT3-positive neurons were estimated in hypothalamic nuclei using a camera lucida device (all sections; 1:5 series). Arcuate nucleus (ARH); retrochiasmatic area
(RCA); ventromedial nucleus (VMH); dorsomedial nucleus (DMH); lateral hypothalamic area (LH); suprachiasmatic nucleus (Sch). Lt = left side; Rt = right side.ever, the reduction in body weight is relatively modest (w20%)(Lepr mice) (McMinn et al., 2004). This approach allowed
Figure 3. Delivery of AAV-FLPe-IRES-eGFP in the
ARH of Lepr/ mice does not lead to Lepr gene re-
activation
Photomicrograph of immunohistochemistry for eGFP
in ARH-missed (A) and ARH-hit (B) Lepr/ mice.
Photomicrograph of immunohistochemistry for lep-
tin-induced phospho-STAT3 in ARH-missed (C) and
ARH-hit (D) Lepr/ mice. Median eminence (ME),
third ventricle (3V), hypothalamic arcuate nucleus
(ARH). Scale bar = 100 m.apy in leptin receptor-deficient rats and showed that this ame-
liorated obesity. This study used adenoviral vectors to trans-
genically express LEPR-B under the control of CMV regulatory
elements. In contrast, our approach used the delivery of
FLPe-recombinase in young FLPe-reactivatalbe, Lepr-null mice
neo/neoCELL METABOLISM : JANUARY 2005us to express endogenous LEPRs at physiological levels only
in neurons that would normally express LEPRs.
Collectively, our data suggest that restoring physiological
leptin signaling in ARH neurons is sufficient to prevent the full
obesity syndrome seen in leptin receptor-deficient mice. How-67
A R T I C L EFigure 4. Unilateral reactivation of the Lepr gene in the hypothalamic arcuate nucleus of Leprneo/neo mice leads to reduced body weight, fat mass, and food intake
A) Body weight curves of ARH-missed (n = 9) and ARH-hit (n = 9) Leprneo/neo mice.
B) Body weight of 12-week-old ARH-missed (n = 9), ARH-hit (n = 9) Leprneo/neo and Lepr+/+ (n = 10) mice.
C) Body weight of 12-week-old ARH-missed (n = 6), ARH-hit (n = 3) Lepr/ mice. Please note that the body weights are displayed separately from the mice in (B)
since the mice have dissimilar genetic backgrounds (C57Bl6/J and 129 in the case of Leprneo/neo mice and C57Bl6/J, 129 and FVB in the case of Lepr/ mice).
D) Fat and lean mass in 12-week-old ARH-missed (n = 9), ARH-hit (n = 6) Leprneo/neo and Lepr+/+ (n = 4) mice were measured by DEXA.
E) Cumulative food intake in ARH-missed (n = 9) and ARH-hit (n = 9) Leprneo/neo mice was collected between ages 5 and 12 weeks.
F) Oxygen consumption was measured with CLAMS in 13-week-old ARH-missed (n = 9) and ARH-hit (n = 5) Leprneo/neo mice. *p < 0.05; **p < 0.01; ***p < 0.001 versus
ARH-missed Leprneo/neo mice.compared to mice with normal leptin signaling. Given the fact
that leptin signaling was restored only in one side of the ARH,
it remains unknown whether bilateral reactivation would lead
to normal body weight homeostasis. However, it is notable that
hypothalamic lesions (including the ARH) in rodents cause sig-
nificant obesity only when performed bilaterally (Elmquist et al.,
1999). The fact that unilateral lesions fail to produce obesity
suggests that unilateral ARH function should be sufficient for
normal body weight regulation.
Interestingly, despite the modest reduction in body weight,
unilateral reactivation markedly improved hyperinsulinemia and
normalized blood glucose levels. Although our study demon-
strates that LEPRs expression by ARH neurons is sufficient to
mediate leptin’s effects on glucose homeostasis, the down-
stream pathways mediating these effects are still unknown. We
propose that melanocortin receptor- and NPY receptor-express-
ing neurons are downstream targets of leptin-responsive ARH
neurons in the leptin-mediated control of glucose homeostasis.
Consistent with this hypothesis, it has been shown that activa-
tion of the central melanocortin pathway leads to increased insu-
lin action (Obici et al., 2001) and decreased insulin levels (Fan et68al., 2000). Since the ARH contains first-order, leptin-responsive
neurons that secrete either the agonist (α-MSH) or the antago-
nist (AGRP) of the melanocortin receptors (Schwartz et al.,
1996, 1997; Cowley et al., 2001; van den Top et al., 2004),
mice with restored leptin signaling in ARH neurons would be
expected to have improved melanocortin signaling and per-
haps insulin action. Moreover, it has been shown that NPY is
required for the development of the full diabetes syndrome in
leptin-deficient mice (Erickson et al., 1996), suggesting that
elevated NPY (as found in Lepob/ob) positively contributes to
their diabetes. Since leptin inhibits NPY-secreting ARH neurons
(van den Top et al., 2004; Roseberry et al., 2004), restoration
of leptin signaling in the ARH is expected to reduce NPY and
therefore to ameliorate glucose homeostasis. Alternatively, it is
possible that the improvement of glucose/insulin homeostasis
is secondary to the reduction in body weight. However, it is
unlikely that this is the sole mechanism underlying the improve-
ment in glucose homeostasis. First, blood glucose levels, while
normalized at 8 weeks after FLPe-recombinase was delivered
into the ARH of Leprneo/neo mice, were not normalized at 4CELL METABOLISM : JANUARY 2005
Leptin action in the hypothalamic arcuate nucleusFigure 5. Unilateral reactivation of the Lepr gene in
the hypothalamic arcuate nucleus of Leprneo/neo
mice leads to improved glucose homeostasis
(A) Serum insulin and (C) blood glucose levels in fed
ARH-missed (n = 9), ARH-hit (n = 6) Leprneo/neo and
Lepr+/+ (n = 3–9) mice. Note that the AAV injections
do not affect glucose homeostasis. Also note that
panels (B) and (D) are separated from (A) and (C)
since the mice have dissimilar genetic backgrounds
(as noted in the legend for Figure 4). (B) Serum
insulin and (D) serum glucose levels in fed ARH-
missed (n = 4), ARH-hit (n = 3) Lepr/ mice. *p <
0.05; **p < 0.01; ***p < 0.001 versus ARH-missed
Leprneo/neo mice.naling in ARH neurons exerts direct control over insulin/glucose tion. Additional studies will be required to reveal the impor-
Figure 6. Unilateral reactivation of the Lepr gene in the hypothalamic arcuate nucleus of Leprneo/neo mice leads to increased locomotor activity
(A) 24 hr (B) nocturnal and (C) diurnal locomotor activity were measured with CLAMS in 13-week-old ARH-missed (n = 9), ARH-hit (n = 5) Leprneo/neo and Lepr+/+ (n =
5) mice. *p < 0.05; **p < 0.01; ***p < 0.001 versus ARH-missed Leprneo/neo mice.weeks after surgery. Since body weight was similarly reduced
at both the 4 and 8 week points, it is unlikely to be the cause
of the normal glycemia at the 8 week point. Moreover, food
restriction experiments in obese mice, which led to a similar
reduction of body weight as that seen in ARH-hit Leprneo/neo
mice, were not able to normalize blood glucose levels
(Schwartz et al., 1996; Yamamoto et al., 2000). In addition, as
detailed below, reactivation of LEPRs in both the VMH and the
lateral hypothalamic area (LH) of Leprneo/neo mice resulted in a
reduction in body weight similar to ARH-hit Leprneo/neo mice.
However, this body weight reduction was not associated with
improved glucose homeostasis. Thus, we conclude that the
improvements in glucose homeostasis are likely to be indepen-
dent of a body weight reduction. This suggests that leptin sig-CELL METABOLISM : JANUARY 2005homeostasis. This concept would be consistent with other
claims that hypothalamic neurons regulate glucose homeosta-
sis (Obici et al., 2001; Fan et al., 2000).
Leptin also exerts a positive action on locomotor activity as
suggested by the fact that Lepob/ob mice are hypoactive and
that their locomotor activity can be normalized by leptin treat-
ment (Pelleymounter et al., 1995). However, the neuronal
groups that mediate this effect of leptin are unknown. Our
study shows that restoring leptin signaling in ARH neurons is
sufficient to normalize locomotor activity. Therefore, this finding
establishes the ARH as a key site for mediating leptin’s effect
on locomotor activity. We suggest the existence of a novel,
yet undefined, neuronal pathway connecting ARH neurons to
cortical and/or subcortical areas regulating voluntary locomo-69
A R T I C L Etance of this hypothesized neurocircuit mediating leptin’s effect
on ambulatory movements.
Further supporting our conclusions that leptin signaling
specifically in the ARH is a major feeding-independent regula-
tor of glucose homeostasis and locomotor activity were physi-
ological data on four Leprneo/neo mice that had brains with
>100 eGFP-positive cells in both the LH and the VMH and
<100 eGFP-positive cells in any other nucleus known to con-
tain Lepr-b mRNA. Like ARH-hit Leprneo/neo mice, these LH +
VMH-hit Leprneo/neo mice hadw20% reduction in body weight
(12-week-old Lepr neo/neo mice: ARH-missed = 47.44 [g] ± 0.56
[n = 9]; ARH-hit = **42.23 [g] ± 1.6 [n = 9]; LH + VMH-hit =
*43.74 [g] ± 2.09 [n = 4]; *p < 0.05, **p < 0.01 versus
ARH-missed). Importantly, despite the reduced body weight,
blood glucose levels and locomotor activity were not normal-
ized in LH + VMH-hit Leprneo/neo mice (blood glucose levels in
12-week-old Leprneo/neo mice: ARH-missed = 300 [mg/dl] ± 48
[9]; LH + VMH-hit = 231 [mg/dl] ± 76 [n = 4]; locomotor activity
in 12-week-old Leprneo/neo mice: ARH-missed = 4447 [counts/
day] ± 631 [n=9]; LH+VMH-hit = 4646 [counts/day] ± 923 [n =
4]). Further analysis, which is in progress in our laboratories, is
needed to definitely assess the physiological importance of
leptin signaling specifically in the LH or the VMH. However,
we predict that leptin’s effects on glucose homeostasis and
locomotor activity are not mediated by LEPRs on neurons con-
tained within these two hypothalamic areas.
In summary, restoration of leptin signaling in ARH neurons
leads to improved, but not normal energy homeostasis. Thus,
other leptin-responsive neuronal groups are likely also to be
important in mediating leptin’s effect on food intake and body
weight. In contrast, LEPRs expression by ARH neurons is suffi-
cient to mediate the majority of leptin’s effects on glucose ho-
meostasis and locomotor activity. Delivery of FLPe in a
neuron-specific fashion by the generation of neuron-specific
FLPe-transgenic Leprneo/neo mice (for example, Npy-FLPe,
Pomc-FLPe, or Agrp-FLPe transgenic mice) will be critical to
reveal the relative contribution of leptin signaling in specific
populations on neurons in the ARH in mediating the varied ef-
fects of leptin.
Experimental procedures
Animal care
Care of all mice was within the Institutional Animal Care and Use Committee
(IACUC) guidelines, and all the procedures were approved by the Beth Israel
Deaconess Medical Center IACUC. Mice were housed individually at 22°C–
24°C using a 14 hr light/10 hr dark cycle with chow food (Tekland F6 Rodent
Diet8664, Harlan Tekland, Madison, Wisconsisn) and water provided ad li-
bitum.
Experimental mice
Leprneo/+ mice were provided by Dr. S. Chua, Jr. (McMinn et al., 2004) . The
genetic background of Leprneo/+ mice is an admixture of C57Bl6/J and 129.
Leprneo/neo and Lepr+/+ male mice were obtained by mating Leprneo/+ mice
with Leprneo/+ mice. Mice were genotyped by PCR with primers (1 and 2)
across the loxP site: 1, 5#-AAT GAA AAA GTT GTT TTG GGA CGA-3# and
2, 5#-CAG GCT TGA GAA CAT GAA CAC AAC AAC-3#. LeprD/D mice are
homozygous for a null LEPR allele lacking exon 17 and were generated as
described previously (Balthasar et al., 2004). The genetic background of
LeprD/D mice is an admixture of C57Bl6/J, 129, and FVB.
AAV-FLPe-IRES-eGFP generation and microinjection
The FLPe gene was cloned into the transfer vector pAAV-M2-IGFP such
that the AAV vector plasmid called here pAAV-FLPe-M2-IGFP was gener-
ated. The virus was generated by tripartite transfection (AAV-rep/cap ex-
pression plasmid, adenovirus miniplasmid, and pAAV-FLPe-M2-IGFP) into70293A cells and purified by heparin column. The eluted virus was dialyzed
against PBS and the titer was assessed by dot blot hybridization. All these
procedures were performed by the Harvard Gene Therapy Initiative core
facility (http://hgti.med.harvard.edu).
Four-week-old Leprneo/neo and LeprD/D male mice were stereotaxically in-
jected with AAV-FLPe-IRES-eGFP into the ARH with a glass micropipette
and air pressure injector system (Chamberlin et al., 1998).
Body and blood composition
Tail vein blood was collected at noon ± 2 hr from fed 8- and 12-week-old
mice. Blood was assayed for glucose level (Fisher Scientific, Morrison
Plains, New Jersey) and successively serum was collected by centrifugation
and assayed for insulin levels using commercially available kits (Crystal
Chem. Inc., Downers Grove, Illinois). Serum was assayed for glucose levels
using an enzymatic glucose oxidase method (Thermo Electron, Victoria,
Australia). After blood was collected, mice were ketamine anesthetized for
dual-energy X-ray absorptiometry (MEC Lunar Corp., Minster, Ohio)
analysis.
Oxygen consumption, locomotor activity, and fertility test
Metabolic rate and physical activity were measured in 13-week-old mice
using a comprehensive lab animal monitoring system (CLAMS, Columbia
Instruments, Columbus, Ohio). Mice were acclimated in the monitoring
chambers for 2 days then data were collected for 3 days. Data analysis was
performed only in mice that did not lose weight during the experiment. After
CLAMS analysis, every mouse was housed with two 7- to 12-week-old FVB
female mice for a period of 6–7 days. Female mice were monitored for the
following 4 weeks and the presence of the offspring was counted as event
of pregnancy. Female control mice were tested for their fertility by breeding
with wild-type male mice. All female mice had events of pregnancy when
bred with wild-type male mice. Food and water were provided ad libitum
during the entire period.
eGFP and P-STAT3 immunohistochemistry
Fed 14-week-old male mice were injected intraperitoneally with 100 g of
recombinant mouse leptin (A.F. Parlow, National Hormone and Peptide Pro-
gram) and perfused with 10% formalin 45 min later. Either eGFP or P-STAT3
immunohistochemistry was performed on microtome cut 25 m brain sec-
tions as described earlier (Liu et al., 2003; Elias et al., 1999; Munzberg et
al. 2003).
Categorization of ARH-hit and ARH-missed Lepr
neo/neo
and Lepr/ mice
Brain sections stained against eGFP by immunohistochemistry were used
for this categorization. The borders of the nuclei containing eGFP-positive
cells were drawn on a paper sheet using a camera lucida device using
darkfield optics and an atlas of the mouse brain (Franklin and Paxinos,
1997). The eGFP-positive cells were plotted and counted such that the
ARH-hit and the ARH-missed were grouped as follows. Brains that had
>100 eGFP-positive cells in the arcuate nucleus of the hypothalamus (all
sections in a 1:5 series) and <100 eGFP-positive cells in any other nucleus
known to contain Lepr-b mRNA (all sections in a 1:5 series) were scored as
ARH-hit. Brains that had <100 eGFP-positive cells in any nucleus known to
contain Lepr-b mRNA (all sections in a 1:5 series) were scored as
ARH-missed. These criteria were established a priori. Also, an individual
blinded to the neuroanatomic categorizations and physiological responses
of each case performed this analysis.
Statistical analysis
Data sets were analyzed for statistical significance using PRISM 3.0
(GraphPad, San Diego, California) for a two-tailed unpaired Student’s t test.
Statistical comparisons shown in Figures 4B, 4D, 5A, 5C, 6A, 6B, and 6C
were made by using one-way ANOVA (Turkey’s post test). All parameters
are expressed as mean ± SEM.
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